- Home
- MVSTW vs HUMAW Comparison
MVSTW vs HUMAW Comparison
Compare MVSTW & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVSTW | HUMAW |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | 1921 | 220 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MVSTW | HUMAW |
|---|---|---|
| Price | $0.12 | $0.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 126.0K | 14.2K |
| Earning Date | 03-14-2025 | 03-21-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $370,989,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 39.03 | N/A |
| 52 Week Low | $0.35 | $1.18 |
| 52 Week High | $0.44 | $1.34 |
Technical Indicators
Market Signals| Indicator | MVSTW | HUMAW |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 42.96 |
| Support Level | $0.07 | $0.09 |
| Resistance Level | $0.16 | $0.12 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 65.71 | 30.85 |
Price Performance
Historical ComparisonAbout MVSTW Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.